Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility are currrently unavailable.

The rosy future of BCL-2 inhibition in chronic lymphocytic leukemia: pursuit of a worthy target.

The rosy future of BCL-2 inhibition in chronic lymphocytic leukemia: pursuit of a worthy target. Leuk Lymphoma. 2015; 56(10):2755-6.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.